PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

NIH-created toxin can kill HIV-infected cells that persist despite treatment

Approach could potentially be part of future HIV cure strategy

2014-01-10
(Press-News.org) Contact information: aura S. Leifman
sivitzl@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
NIH-created toxin can kill HIV-infected cells that persist despite treatment Approach could potentially be part of future HIV cure strategy A team including University of North Carolina and NIH scientists has demonstrated in a mouse model that an HIV-specific poison can kill cells in which the virus is actively reproducing despite antiretroviral therapy. According to the researchers, such a targeted poison could complement antiretroviral therapy, which dramatically reduces the replication of HIV in infected cells but does not eliminate them.

The 40 mice in the experiment were bioengineered to have a human immune system. They were infected with HIV for several months and then given a combination of antiretroviral drugs for four weeks. Half of the animals subsequently received a two-week dose of a genetically designed, HIV-specific poison, or immunotoxin, to complement the antiretrovirals, while the other half continued receiving antiretrovirals alone. The scientists found that, compared to antiretrovirals alone, the addition of the immunotoxin significantly reduced both the number of HIV-infected cells producing the virus in multiple organs and the level of HIV in the blood. According to the researchers, these findings, coupled with results from previous studies, suggest that treating certain HIV-infected people with a combination of antiretrovirals and an immunotoxin might help achieve sustained disease remission, in which HIV can be controlled or eliminated without a lifetime of antiretroviral therapy. However, further study is required, the scientists write.

The immunotoxin, known as 3B3-PE38, was created in 1998 in the laboratories of Edward A. Berger, Ph.D., of the National Institute of Allergy and Infectious Diseases, and Ira Pastan, Ph.D., of the National Cancer Institute, both part of NIH. This genetically modified bacterial toxin targets HIV-infected cells and becomes internalized by them, shutting down protein synthesis and triggering cell death. The study was designed by Drs. Berger and Pastan in collaboration with J. Victor Garcia, Ph.D., and colleagues at the University of North Carolina School of Medicine, where the experiments were performed.

###

ARTICLE: PW Denton et al. Targeted cytotoxic therapy kills persisting HIV-infected cells during ART. PLOS Pathogens DOI: ppat.1003872 (2014).

NIAID Director Anthony S. Fauci, M.D., and Edward A. Berger, Ph.D., senior investigator in the NIAID Laboratory of Viral Diseases, are available for comment.

CONTACT: To schedule interviews, please contact Laura S. Leifman, (301) 402-1663, sivitzl@niaid.nih.gov.

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.

NIH...Turning Discovery Into Health®

END



ELSE PRESS RELEASES FROM THIS DATE:

Researchers develop tool to determine individual risk of prostate cancer overdiagnosis

2014-01-10
Researchers develop tool to determine individual risk of prostate cancer overdiagnosis Nomogram aims to enable informed decision-making and personalized treatment SEATTLE - Studies have found that prostate cancer is overdiagnosed in up to 42 percent ...

Study: Athlete's first reaction in victory is dominance

2014-01-10
Study: Athlete's first reaction in victory is dominance Body language, also called 'triumph,' stronger in victors from cultures that emphasize hierarchy SAN FRANCISCO -- Upon victory, an athlete's initial and instinctive reaction is one that displays dominance ...

Researchers pursuing arthritis protein

2014-01-10
Researchers pursuing arthritis protein Chronic inflammation poses something of a mystery for researchers. If we become infected, the body immediately takes steps to repair and tidy it up. This process manifests itself as inflammation, which stems from a high ...

Drought and downing equal vulture supermarkets

2014-01-09
Drought and downing equal vulture supermarkets NEW YORK (EMBARGO: Wednesday, January 8, 2014 5 PM EST, USA) African vultures are famous for quickly finding carcasses; so much so that they are considered clairvoyants in parts of Africa. But just how do vultures ...

UCLA life scientists, colleagues differentiate microbial good and evil

2014-01-09
UCLA life scientists, colleagues differentiate microbial good and evil To safely use bacteria in agriculture to help fertilize crops, it is vital to understand the difference between harmful and healthy strains. The bacterial genus Burkholderia, ...

Elephant shark genome provides new insights into bone formation and adaptive immunity in humans

2014-01-09
Elephant shark genome provides new insights into bone formation and adaptive immunity in humans A*STAR-led international consortium completely decodes the first shark-family member genome 1. Singapore, Jan, 09, 2014 ...

Researchers discover how vascular disease activates autoimmune disorders

2014-01-09
Researchers discover how vascular disease activates autoimmune disorders The hardening of the arteries, also called atherosclerosis, that can lead to heart attack or stroke. has also been linked to autoimmune disorders. It has not been clear why these diseases are related, ...

JCI early table of contents for Jan. 9, 2014

2014-01-09
JCI early table of contents for Jan. 9, 2014 Engineered anti-toxin antibodies improve efficacy The effectiveness of toxin-neutralizing antibodies is considered to be mediated through the interaction of the variable region of the antibody and the toxin; ...

Engineered anti-toxin antibodies improve efficacy

2014-01-09
Engineered anti-toxin antibodies improve efficacy The effectiveness of toxin-neutralizing antibodies is considered to be mediated through the interaction of the variable region of the antibody and the toxin; however, recent studies suggest that the constant ...

Mice exposed to retinoid deficiency in utero exhibit bronchial hyperresponsiveness as adults

2014-01-09
Mice exposed to retinoid deficiency in utero exhibit bronchial hyperresponsiveness as adults Individuals with asthma and COPD are subject to debilitating bronchospasm as a result of airways that are hyperresponsive to stimuli. Factors that lead to the ...

LAST 30 PRESS RELEASES:

AI can spot which patients need treatment to prevent vision loss in young adults

Half of people stop taking popular weight-loss drug within a year, national study finds

Links between diabetes and depression are similar across Europe, study of over-50s in 18 countries finds

Smoking increases the risk of type 2 diabetes, regardless of its characteristics

Scientists trace origins of now extinct plant population from volcanically active Nishinoshima

AI algorithm based on routine mammogram + age can predict women’s major cardiovascular disease risk

New hurdle seen to prostate screening: primary-care docs

MSU researchers explore how virtual sports aid mental health

Working together, cells extend their senses

Cheese fungi help unlock secrets of evolution

Researchers find brain region that fuels compulsive drinking

Mental health effects of exposure to firearm violence persist long after direct exposure

Research identifies immune response that controls Oropouche infection and prevents neurological damage

University of Cincinnati, Kent State University awarded $3M by NSF to share research resources

Ancient DNA reveals deeply complex Mastodon family and repeated migrations driven by climate change

Measuring the quantum W state

Researchers find a way to use antibodies to direct T cells to kill Cytomegalovirus-infected cells

Engineers create mini microscope for real-time brain imaging

Funding for training and research in biological complexity

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: September 12, 2025

ISSCR statement on the scientific and therapeutic value of human fetal tissue research

Novel PET tracer detects synaptic changes in spinal cord and brain after spinal cord injury

Wiley advances Knowitall Solutions with new trendfinder application for user-friendly chemometric analysis and additional enhancements to analytical workflows

Benchmark study tracks trends in dog behavior

OpenAI, DeepSeek, and Google vary widely in identifying hate speech

Research spotlight: Study identifies a surprising new treatment target for chronic limb threatening ischemia

Childhood loneliness and cognitive decline and dementia risk in middle-aged and older adults

Parental diseases of despair and suicidal events in their children

Acupuncture for chronic low back pain in older adults

Acupuncture treatment improves disabling effects of chronic low back pain in older adults

[Press-News.org] NIH-created toxin can kill HIV-infected cells that persist despite treatment
Approach could potentially be part of future HIV cure strategy